-
AbbVie Inc. (ABBV $223.16)
-
Danaher Corporation (DHR $186.06)
-
Eli Lilly and Company (LLY $726.51)
-
Thermo Fisher Scientific Inc (TMO $462.04)
-
Lantheus Holdings Inc. (LNTH $50.62)
Q: As I'm sure you're aware, this is a name that has been drifting steadily lower since it ranked on its disappointing latest earnings release. Do you think it remains a premier us drug manufacturer worth holding or would you recommend redeploying the capital into another name?